Capstone Holding Corp. Files S-1/A Amendment

Ticker: CAPS · Form: S-1/A · Filed: Jan 27, 2025 · CIK: 887151

Sentiment: neutral

Topics: sec-filing, registration-statement, amendment

TL;DR

Capstone Holding Corp. (CAPS) filed an S-1/A. Looks like they're updating their public offering docs.

AI Summary

Capstone Holding Corp. filed an S-1/A amendment on January 27, 2025, for its registration statement. The company, previously known as Capstone Therapeutics Corp. and Orthologic Corp., is incorporated in Delaware and headquartered in Alsip, IL. This filing relates to SEC Act of 1933, with SEC file number 333-284105.

Why It Matters

This S-1/A filing indicates an update to Capstone Holding Corp.'s registration statement, which is a crucial step for companies looking to offer securities to the public or make significant changes to their existing public offerings.

Risk Assessment

Risk Level: medium — S-1/A filings are typically associated with significant corporate actions like public offerings, which inherently carry market and regulatory risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this S-1/A filing?

This S-1/A filing is an amendment to the Registration Statement filed under the Securities Act of 1933, indicating updates or changes to the company's initial filing.

What were Capstone Holding Corp.'s previous names?

The company was formerly known as Capstone Therapeutics Corp. and prior to that, ORTHOLOGIC CORP.

When was the company incorporated?

The company was incorporated in Delaware.

What is the business address of Capstone Holding Corp.?

The business address is 5141 W. 122nd Street, Alsip, IL 60803.

What is the SEC file number associated with this registration?

The SEC file number is 333-284105.

Filing Stats: 4,060 words · 16 min read · ~14 pages · Grade level 14.3 · Accepted 2025-01-27 06:24:39

Key Financial Figures

Filing Documents

Risk Factors

Risk Factors   14

Use of Proceeds

Use of Proceeds   29 Cautionary Note Regarding Forward-Looking Statements   30 Market For Our Common Stock and Related Stockholder Matters   31 Capitalization   32

Dilution

Dilution   33 Management’s Discussion and Analysis of Financial Condition and Results of Operations   34

Business

Business   43 Directors and Executive Officers   53

Executive Compensation

Executive Compensation   57

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management   59 Certain Relationships and Related Party Transactions   61

Description of Capital Stock

Description of Capital Stock   64 Shares Eligible for Future Sale   67 Material U.S. Federal Income Tax Considerations   68

Underwriting

Underwriting   73 Transfer Agent and Registrar   77 Legal Matters   77 Experts   77 Where You Can Find More Information   77 Index to Consolidated Financial Statements   F-1 You should rely only on information contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. We have not, and the underwriter has not, authorized anyone to provide you with additional information or information different from that contained in this prospectus or in any free writing prospectus. Neither the delivery of this prospectus nor the sale of our securities means that the information contained in this prospectus or any free writing prospectus is correct after the date of this prospectus or such free writing prospectus. This prospectus is not an offer to sell or the solicitation of an offer to buy our securities under any circumstances in which the offer or solicitation is unlawful or in any state or other jurisdiction where the offer is not permitted. The information in this prospectus is accurate only as of the date on the front cover of this prospectus and the information in any free writing prospectus that we may provide you in connection with this offering is accurate only as of the date of that free writing prospectus. Our business, financial condition, results of operations and prospects may have changed since those dates. No person is authorized in connection with this prospectus to give any information or to make any representations about us, the securities offered hereby or any matter discussed in this prospectus, other than the information and representations contained in this prospectus. If any other information or representation is given or made, such information or representation may not be relied upon as having been authorized by us. Through and including __, 2025 (the 25 th  day after the date of this prospectus), all dealers e

Description of Capital Stock

Description of Capital Stock Below is a summary of each of our classes of capital stock: Common Stock As of January 23, 2025, there were 157,610 shares of Common Stock outstanding. Preferred Stock We have 5,000 shares of authorized preferred stock, the terms of which may be fixed by our Board of Directors (the “Board”). We presently have no outstanding shares of preferred stock. Our Board of Directors has the authority, without stockholder approval, to create and issue one or more series of such preferred stock and to determine the voting, dividend and other rights of holders of such preferred stock. If we raise additional funds to continue operations, we may issue preferred stock. The issuance of any of such series of preferred stock may have an adverse effect on the holders of common stock. The Board of Directors of the Company approved a Tax Benefit Preservation Plan (“Benefit Plan”) dated April 18, 2017, between the Company and Computershare. The Benefit Plan and the exercise

View Full Filing

View this S-1/A filing on SEC EDGAR

View on Read The Filing